Nifty

:

17800.30

Sensex

:

60093.00

138.15 (0.78%)
543.10 (0.91%)

Login

Nifty
Sensex

:
:

17800.30
60093.00

138.15 (0.78%)
543.10 (0.91%)

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

72/99

BSE: 507789 | NSE: JAGSNPHARM

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

930.03
57.37
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

903.88
1.13%
7.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.11
12.31
12.55

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.89
-
24.78

PAT CAGR (%)

10 Years
5 Years
3 Years

26.75
-
35.53

P:E (Median)

8 Years
5 Years
3 Years

18.81
15.42
18.77

P:BV (Average)

8 Years
5 Years
3 Years

3.68
3.68
3.68

EV:EBITDA (Average)

8 Years
5 Years
3 Years

275.83
13.43
15.31

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 60.53 58.39 3.67% 60.60 54.05 12.12% 52.14 42.84 21.71% 54.47 57.10 -4.61%
Expenses 47.63 48.99 -2.78% 54.18 44.78 20.99% 51.51 37.72 36.56% 48.86 50.62 -3.48%
EBITDA 12.90 9.40 37.23% 6.42 9.27 -30.74% 0.63 5.12 -87.70% 5.61 6.48 -13.43%
EBIDTM 21.31% 16.10% 10.59% 17.16% 1.20% 11.94% 10.30% 11.35%
Other Income 1.12 0.29 286.21% 0.31 0.82 -62.20% 0.28 2.66 -89.47% 1.95 0.53 267.92%
Interest 0.03 0.06 -50.00% 0.01 0.11 -90.91% 0.06 0.13 -53.85% 0.06 0.14 -57.14%
Depreciation 0.20 0.23 -13.04% 0.19 0.28 -32.14% 0.65 0.26 150.00% 0.37 0.27 37.04%
PBT 13.79 9.40 46.70% 0.72 9.71 -92.58% 0.20 7.38 -97.29% 7.14 6.61 8.02%
Tax 3.38 2.83 19.43% 0.35 2.86 -87.76% 0.18 2.28 -92.11% 1.73 1.18 46.61%
PAT 10.41 6.56 58.69% 0.37 6.85 -94.60% 0.02 5.10 -99.61% 5.41 5.43 -0.37%
PATM 17.20% 11.24% 0.61% 12.67% 0.05% 11.90% 9.93% 9.51%
EPS 3.97 2.51 58.17% 0.14 2.61 -94.64% 0.01 1.95 -99.49% 2.06 2.07 -0.48%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 227.74 226.10 187.95 158.57 166.83 126.53 143.87 143.49 138.15 143.85 166.46 Net Sales Growth 7.23% 20.30% 18.53% -4.95% 31.85% -12.05% 0.26% 3.87% -3.96% -13.58% Cost Of Goods Sold 92.18 95.78 80.78 56.19 72.85 61.11 58.95 59.13 68.68 64.71 86.16 Gross Profit 135.56 130.31 107.17 102.38 93.98 65.42 84.92 84.36 69.47 79.14 80.30 GP Margin 59.53% 57.63% 57.02% 64.56% 56.33% 51.70% 59.03% 58.79% 50.29% 55.02% 48.24% Total Expenditure 202.18 200.30 168.87 150.04 157.49 137.64 138.10 131.68 129.42 133.17 156.41 Power & Fuel Cost - 0.47 0.52 0.76 1.41 1.00 2.12 2.26 1.77 2.23 2.55 % Of Sales - 0.21% 0.28% 0.48% 0.85% 0.79% 1.47% 1.58% 1.28% 1.55% 1.53% Employee Cost - 57.68 53.98 50.37 46.61 41.88 40.95 37.84 32.11 37.83 37.25 % Of Sales - 25.51% 28.72% 31.77% 27.94% 33.10% 28.46% 26.37% 23.24% 26.30% 22.38% Manufacturing Exp. - 1.05 0.62 0.51 0.73 0.96 1.34 1.70 1.01 1.57 2.01 % Of Sales - 0.46% 0.33% 0.32% 0.44% 0.76% 0.93% 1.18% 0.73% 1.09% 1.21% General & Admin Exp. - 28.56 18.75 23.55 19.03 16.31 16.44 13.61 9.64 8.55 8.87 % Of Sales - 12.63% 9.98% 14.85% 11.41% 12.89% 11.43% 9.48% 6.98% 5.94% 5.33% Selling & Distn. Exp. - 15.32 12.99 17.45 13.20 11.25 13.74 12.96 11.53 14.36 15.45 % Of Sales - 6.78% 6.91% 11.00% 7.91% 8.89% 9.55% 9.03% 8.35% 9.98% 9.28% Miscellaneous Exp. - 1.45 1.22 1.20 3.66 5.14 4.56 4.19 4.67 3.92 15.45 % Of Sales - 0.64% 0.65% 0.76% 2.19% 4.06% 3.17% 2.92% 3.38% 2.73% 2.47% EBITDA 25.56 25.80 19.08 8.53 9.34 -11.11 5.77 11.81 8.73 10.68 10.05 EBITDA Margin 11.22% 11.41% 10.15% 5.38% 5.60% -8.78% 4.01% 8.23% 6.32% 7.42% 6.04% Other Income 3.66 3.34 4.39 2.53 1.43 0.46 0.47 0.66 0.11 0.06 0.32 Interest 0.16 0.29 0.51 0.51 0.75 0.66 2.64 5.30 4.46 5.38 5.13 Depreciation 1.41 1.53 1.09 1.13 1.02 0.32 1.99 3.09 2.71 2.83 2.71 PBT 21.85 27.32 21.87 9.41 9.00 -11.63 1.60 4.08 1.67 2.53 2.54 Tax 5.64 7.73 4.81 1.54 1.79 -0.08 2.53 0.82 0.50 0.41 0.70 Tax Rate 25.81% 28.29% 21.99% 16.37% 19.89% 0.69% 17.57% 20.10% 29.94% 16.21% 27.56% PAT 16.21 19.59 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 PAT before Minority Interest 16.21 19.59 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.12% 8.66% 9.08% 4.96% 4.33% -9.13% 8.24% 2.26% 0.85% 1.47% 1.10% PAT Growth -32.29% 14.83% 116.77% 9.00% - - 264.92% 177.78% -44.81% 15.85% EPS 6.19 7.48 6.51 3.00 2.76 -4.41 4.53 1.24 0.45 0.81 0.70

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 130.86 121.93 111.03 104.47 98.05 109.91 98.36 95.43 98.59 98.37 Share Capital 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 117.76 108.83 97.93 91.37 84.95 96.81 85.27 82.33 85.49 85.27 Non-Current Liabilities 3.44 1.88 3.09 3.12 3.19 3.26 3.61 3.60 4.08 4.50 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 Long Term Provisions 1.26 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 34.16 40.40 34.57 28.19 28.58 29.44 57.31 55.19 53.58 50.13 Trade Payables 16.29 18.05 11.71 11.86 9.09 8.98 9.73 7.87 5.08 6.51 Other Current Liabilities 9.42 10.89 8.16 5.60 6.10 7.12 6.61 6.24 5.48 3.99 Short Term Borrowings 0.00 6.79 6.40 3.79 8.30 7.93 38.49 39.31 35.96 33.09 Short Term Provisions 8.45 4.67 8.30 6.95 5.09 5.41 2.48 1.77 7.06 6.55 Total Liabilities 168.46 164.21 148.69 135.78 129.82 142.61 159.28 154.22 156.25 153.00 Net Block 24.75 25.72 24.44 21.64 21.32 21.59 51.61 51.96 56.41 58.35 Gross Block 60.28 60.12 58.17 55.00 53.66 52.88 90.35 87.61 87.01 85.75 Accumulated Depreciation 35.53 34.40 33.74 33.36 32.34 31.28 38.74 35.65 30.60 27.41 Non Current Assets 57.68 43.73 52.39 38.23 35.20 32.50 58.32 58.43 64.94 66.46 Capital Work in Progress 0.00 0.00 1.90 3.95 3.04 0.00 0.00 0.00 2.35 2.33 Non Current Investment 20.58 12.06 11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 9.93 5.66 14.53 12.63 10.84 10.90 6.71 6.47 6.19 5.78 Other Non Current Assets 2.42 0.29 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 110.78 120.48 96.31 97.56 94.61 110.11 100.96 95.79 91.31 86.54 Current Investments 22.14 3.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 29.74 29.72 29.32 32.69 51.43 47.62 39.84 33.06 30.59 30.07 Sundry Debtors 15.58 12.66 21.45 20.75 25.15 39.41 41.69 44.89 45.22 42.20 Cash & Bank 26.15 60.23 40.49 38.53 14.51 20.06 15.53 15.02 12.60 10.34 Other Current Assets 17.16 0.27 0.52 0.94 3.51 3.03 3.90 2.83 2.90 3.93 Short Term Loans & Adv. 13.55 14.34 4.52 4.64 3.27 2.80 3.90 2.83 2.90 3.93 Net Current Assets 76.62 80.08 61.74 69.37 66.03 80.68 43.65 40.60 37.73 36.41 Total Assets 168.46 164.21 148.70 135.79 129.81 142.61 159.28 154.22 156.25 153.00

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 5.60 28.22 11.89 30.90 -1.58 -3.24 9.04 4.30 7.52 12.05 PBT 27.32 21.87 9.41 9.00 -11.63 14.40 4.08 1.67 2.53 2.54 Adjustment 2.91 -2.09 -0.57 0.33 1.26 -8.63 7.73 7.05 8.15 7.52 Changes in Working Capital -17.13 11.59 4.84 19.71 8.79 -6.13 -1.96 -4.09 -2.65 2.50 Cash after chg. in Working capital 13.10 31.37 13.69 29.05 -1.58 -0.36 9.85 4.63 8.02 12.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.50 -3.15 -1.80 1.85 0.00 -2.88 -0.82 -0.33 -0.51 -0.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -26.21 -2.26 -11.07 -0.83 -3.37 41.29 -2.09 -0.46 -1.21 -3.39 Net Fixed Assets -0.16 -0.05 -1.12 -2.25 -3.82 37.47 -2.74 1.75 -1.28 -3.71 Net Investments -27.41 -3.92 -11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 1.36 1.71 1.44 1.42 0.45 3.82 0.65 -2.21 0.07 0.32 Cash from Financing Activity -12.30 -6.83 -1.82 -6.05 -0.60 -33.52 -6.43 -1.42 -4.04 -8.19 Net Cash Inflow / Outflow -32.91 19.13 -1.01 24.02 -5.55 4.53 0.52 2.41 2.26 0.46 Opening Cash & Equivalents 58.94 39.81 40.82 14.51 20.06 15.53 15.02 12.60 10.34 9.88 Closing Cash & Equivalent 26.03 58.94 39.81 38.53 14.51 20.06 15.53 15.02 12.60 10.34

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 46.96 43.55 39.39 36.89 34.43 38.96 34.55 33.43 32.86 32.63 ROA 11.78% 10.90% 5.53% 5.43% -8.48% 7.86% 2.08% 0.75% 1.37% 1.19% ROE 16.52% 15.70% 7.88% 7.72% -12.01% 12.32% 3.65% 1.35% 2.47% 2.15% ROCE 22.64% 19.43% 9.46% 9.80% -10.52% 14.26% 7.32% 4.93% 6.57% 6.42% Fixed Asset Turnover 3.76 3.18 2.80 3.07 2.38 2.03 1.62 1.59 1.68 2.01 Receivable days 22.80 33.13 48.57 50.22 93.07 102.03 109.58 118.23 109.72 90.52 Inventory Days 48.00 57.34 71.38 92.03 142.78 110.02 92.27 83.52 76.13 69.93 Payable days 65.42 67.24 34.46 31.91 27.07 22.17 21.36 15.26 9.95 12.35 Cash Conversion Cycle 5.37 23.23 85.49 110.33 208.78 189.88 180.49 186.49 175.90 148.10 Total Debt/Equity 0.00 0.06 0.06 0.04 0.09 0.08 0.43 0.45 0.42 0.39 Interest Cover 96.82 43.59 19.31 13.08 -16.69 6.44 1.77 1.37 1.47 1.49

Top Investors:

vanaja sundar iyer

mukul mahavir agrawal

investor education and protection fund (iepf)

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharma - Quarterly Results
9th Nov 2022, 19:09 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback